LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 32 of 483
Next
>>
>
776 to 800 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Buparlisib	0.37	uM	LJP5	2	H04	72	hr	1334	2659	3970	0.6696	0.5024
BT-20	Buparlisib	0.37	uM	LJP5	3	H04	72	hr	1334	2648	3970	0.6669	0.4982
BT-20	BX-912	0.37	uM	LJP5	1	L22	72	hr	1334	3177	3970	0.8001	0.6989
BT-20	BX-912	0.37	uM	LJP5	2	L22	72	hr	1334	3931	3970	0.9900	0.9849
BT-20	BX-912	0.37	uM	LJP5	3	L22	72	hr	1334	4151	3970	1.0454	1.0683
BT-20	Canertinib	0.37	uM	LJP6	1	H10	72	hr	1334	3711	3970	0.9346	0.9014
BT-20	Canertinib	0.37	uM	LJP6	2	H10	72	hr	1334	3413	3970	0.8595	0.7884
BT-20	Canertinib	0.37	uM	LJP6	3	H10	72	hr	1334	3425	3970	0.8625	0.7929
BT-20	Celastrol	0.37	uM	LJP6	1	G10	72	hr	1334	3913	3970	0.9854	0.9780
BT-20	Celastrol	0.37	uM	LJP6	2	G10	72	hr	1334	3626	3970	0.9131	0.8692
BT-20	Celastrol	0.37	uM	LJP6	3	G10	72	hr	1334	3497	3970	0.8807	0.8202
BT-20	CGP60474	0.37	uM	LJP5	1	F04	72	hr	1334	435	3970	0.1096	-0.3413
BT-20	CGP60474	0.37	uM	LJP5	2	F04	72	hr	1334	365	3970	0.0919	-0.3678
BT-20	CGP60474	0.37	uM	LJP5	3	F04	72	hr	1334	430	3970	0.1083	-0.3432
BT-20	CGP60474	0.37	uM	LJP6	1	G04	72	hr	1334	494	3970	0.1244	-0.3189
BT-20	CGP60474	0.37	uM	LJP6	2	G04	72	hr	1334	563	3970	0.1418	-0.2927
BT-20	CGP60474	0.37	uM	LJP6	3	G04	72	hr	1334	469	3970	0.1181	-0.3284
BT-20	CHIR-99021	0.37	uM	LJP6	1	P16	72	hr	1334	3630	3970	0.9142	0.8707
BT-20	CHIR-99021	0.37	uM	LJP6	2	P16	72	hr	1334	4225	3970	1.0640	1.0964
BT-20	CHIR-99021	0.37	uM	LJP6	3	P16	72	hr	1334	3809	3970	0.9592	0.9386
BT-20	CP724714	0.37	uM	LJP5	1	A10	72	hr	1334	3497	3970	0.8807	0.8202
BT-20	CP724714	0.37	uM	LJP5	2	A10	72	hr	1334	3592	3970	0.9046	0.8563
BT-20	CP724714	0.37	uM	LJP5	3	A10	72	hr	1334	3900	3970	0.9821	0.9731
BT-20	CP466722	0.37	uM	LJP5	1	I10	72	hr	1334	4022	3970	1.0129	1.0194
BT-20	CP466722	0.37	uM	LJP5	2	I10	72	hr	1334	3964	3970	0.9983	0.9974

|<
<<
Previous
Page 32 of 483
Next
>>
>
776 to 800 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)